Teodora Djikic

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Integration of 3D-QSAR, molecular docking, and machine learning techniques for rational design of nicotinamide-based SIRT2 inhibitors.

Integration of 3D-QSAR, molecular docking, and machine learning techniques for rational design of nicotinamide-based SIRT2 inhibitors.

Journal: Computational biology and chemistry

Published: May 23, 2024

Discovery of new chemotypes of dual 5-HT2A/D2 receptor antagonists with a strategy of drug design methodologies.

Discovery of new chemotypes of dual 5-HT2A/D2 receptor antagonists with a strategy of drug design methodologies.

Journal: Future medicinal chemistry

Published: June 08, 2022

Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein.

Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein.

Journal: Molecules (Basel, Switzerland)

Published: July 15, 2021

Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates.

Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: July 12, 2021

Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease.

Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease.

Journal: European journal of medicinal chemistry

Published: February 23, 2021

Correction to Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease.

Correction to Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease.

Journal: Journal of medicinal chemistry

Published: September 14, 2020

An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease.

An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease.

Journal: Molecular informatics

Published: July 30, 2020

Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease.

Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease.

Journal: Journal of medicinal chemistry

Published: March 10, 2020

In silico identification of novel 5-HT2A antagonists supported with ligand- and target-based drug design methodologies.

In silico identification of novel 5-HT2A antagonists supported with ligand- and target-based drug design methodologies.

Journal: Journal of biomolecular structure & dynamics

Published: March 07, 2020

Deciphering Imidazoline Off-targets by Fishing in the Class A of GPCR field.

Deciphering Imidazoline Off-targets by Fishing in the Class A of GPCR field.

Journal: Molecular informatics

Published: November 29, 2019

In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs.

In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs.

Journal: Frontiers in chemistry

Published: September 28, 2019

Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors.

Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors.

Journal: Molecules (Basel, Switzerland)

Published: July 02, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026